External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Inne Nauwelaers; Nele Laudus; Dieter Peeters; Balazs Acs; Carsten Denkert; Stefan Michiels; Hugo Horlings; Kalliopi P. Siziopikou; Scott Ely; Dimitrios Zardavas; Roberts Mustimbo; John Bartlett; Giuseppe Floris; Johan Hartman; Carolien H.M. van Deurzen; Dorien Ceusters; Els Dequeker; Roberto Salgado

doi:10.3390/cancers14153762

External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert, Stefan Michiels, Hugo Horlings, Kalliopi P. Siziopikou, Scott Ely, Dimitrios Zardavas, Roberts Mustimbo, John Bartlett, Giuseppe Floris, Johan Hartman, Carolien H.M. van Deurzen, Dorien Ceusters, Els Dequeker, Roberto Salgado

Résultats de recherche: Contribution à un journal › Editorial

Résumé

New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

langue originale	Anglais
Numéro d'article	3762
journal	Cancers
Volume	14
Numéro de publication	15
Les DOIs	https://doi.org/10.3390/cancers14153762
état	Publié - 1 août 2022

Accès au document

10.3390/cancers14153762

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Nauwelaers, I., Laudus, N., Peeters, D., Acs, B., Denkert, C., Michiels, S., Horlings, H., Siziopikou, K. P., Ely, S., Zardavas, D., Mustimbo, R., Bartlett, J., Floris, G., Hartman, J., van Deurzen, C. H. M., Ceusters, D., Dequeker, E., & Salgado, R. (2022). External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices. Cancers, 14(15), Article 3762. https://doi.org/10.3390/cancers14153762

@article{11105c06254e4ae988acd7e3412941ad,

title = "External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices",

abstract = "New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.",

author = "Inne Nauwelaers and Nele Laudus and Dieter Peeters and Balazs Acs and Carsten Denkert and Stefan Michiels and Hugo Horlings and Siziopikou, {Kalliopi P.} and Scott Ely and Dimitrios Zardavas and Roberts Mustimbo and John Bartlett and Giuseppe Floris and Johan Hartman and {van Deurzen}, {Carolien H.M.} and Dorien Ceusters and Els Dequeker and Roberto Salgado",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = aug,

day = "1",

doi = "10.3390/cancers14153762",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

number = "15",

}

Nauwelaers, I, Laudus, N, Peeters, D, Acs, B, Denkert, C, Michiels, S, Horlings, H, Siziopikou, KP, Ely, S, Zardavas, D, Mustimbo, R, Bartlett, J, Floris, G, Hartman, J, van Deurzen, CHM, Ceusters, D, Dequeker, E & Salgado, R 2022, 'External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices', Cancers, VOL. 14, Numéro 15, 3762. https://doi.org/10.3390/cancers14153762

TY - JOUR

T1 - External Quality Assessment 2.0

T2 - The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

AU - Nauwelaers, Inne

AU - Laudus, Nele

AU - Peeters, Dieter

AU - Acs, Balazs

AU - Denkert, Carsten

AU - Michiels, Stefan

AU - Horlings, Hugo

AU - Siziopikou, Kalliopi P.

AU - Ely, Scott

AU - Zardavas, Dimitrios

AU - Mustimbo, Roberts

AU - Bartlett, John

AU - Floris, Giuseppe

AU - Hartman, Johan

AU - van Deurzen, Carolien H.M.

AU - Ceusters, Dorien

AU - Dequeker, Els

AU - Salgado, Roberto

PY - 2022/8/1

Y1 - 2022/8/1

N2 - New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

AB - New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

UR - http://www.scopus.com/inward/record.url?scp=85136828863&partnerID=8YFLogxK

U2 - 10.3390/cancers14153762

DO - 10.3390/cancers14153762

M3 - Editorial

AN - SCOPUS:85136828863

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 15

M1 - 3762

ER -